{ Upper Abdominal Debulking of Gynecologic Malignancies Shaun McKenzie, MD Assistant Professor of Surgery University of Kentucky.

Slides:



Advertisements
Similar presentations
Is there a role for surgery in metastatic colorectal cancer?
Advertisements

Update on Ovarian Cancer
St. John Providence Health System
IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
Cornelis J.H. van de Velde, MD, PhD,FRCPS(hon)FACS(hon) Professor of Surgery President ECCO - the European Cancer Organization Past-President European.
Intraperitoneal therapy in ovarian cancer Edward L. Trimble, MD, MPH National Cancer Institute, USA.
Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer Spanish Association of Surgeons Madrid 11 November 2002 The University.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Trials in gastric cancer surgery Presenter Dr Pankaj Kumar Garg Moderator Dr Sunil Kumar.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Radiofrequency Ablation of Lung Cancer
Management of Colorectal Liver Metastasis
Materials & Methods Prospective study in tertiary oncology centre. PJ used in 15 laparotomies and 6 laparoscopic debulking. Patient demographics, intra.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Neoadjuvant Chemotherapy in Ovarian Cancer Key issues in trial design.
Dr. LP Si Tseung Kwan O Hospital. Introduction CA stomach is the 4 th most commonly diagnosed malignancy worldwide 2 nd most common cause of cancer-related.
Dr.Yousefi Gynecologist Oncologist Surgical Staging Conservative Surgery Cytoreduction Surgery Optimal Cytoreduction Intraperitoneal Chemotherapy Neoadjuvant.
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Cancer Ignace Vergote, MD PhD University Hospitals Leuven, Belgium IGCS Santa.
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
Laparoscopic Surgical Management of Epithelial Ovarian Cancer Cagatay Taskiran, MD, Assoc. Prof. VKV American Hospital, Division of Gynecologic Oncology.
4% of all female cancers 25% of all gynecologic cancers life time risk: 1/70 ¾ advanced stage most lethal Epithelial Ovarian Cancer:
Pathologic Analysis of Tumour Destruction with Neutral Plasma in Epithelial Ovarian Carcinoma Madhuri TK 1, Butler-Manuel SA 1, Tailor A 1 & Haagsma B.
1 Terri Conner,PhD Nybeck Analytics Partnership for Patients 14 th May 2012 USE OF MEDICARE DIAGNOSIS AND PROCEDURE CODES TO IMPROVE DETECTION OF SURGICAL.
Primary Debulking for Bulky Advanced Stage Ovarian Cancer Ginger J. Gardner, MD Director, Survivorship Program Gynecology Service, Department of Surgery.
10 Minutes Talk 吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Sep 08, 2008.
Lymphadenectomy in Epithelial Ovarian Cancer
Neoadjuvant followed by interval cytoreduction Francesco Fanfani Gynecologic Oncology Dpt. Obstetrics & Gynecology Catholic University - Rome
Laparoscopic Pancreatectomy Attila Nakeeb, M.D., F.A.C.S. Department of Surgery Indiana University School of Medicine 7th Annual Symposium on Gastrointestinal.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Quantifying the Morbidity of the Unplanned Sarcoma Excision
Minimally Invasive Esophagectomy Dmitry Oleynikov M.D. Associate Professor of Surgery Joseph and Richard Still Faculty Fellow in Medicine Director of Minimally.
Cryosurgical Treatment of Tumors of the Liver and Pancreas Patyutko Y.I., Podluzhny D.V., Gakhramanov A.D. Russian Cancer Research Center, Moscow, 2013.
Gastric Cancer Resections in BC: How are we doing? Trevor D Hamilton MD FRCSC Surgical Oncology Network November 7, 2015.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
Who can benefit from chemotherapy holidays after first-line therapy for advanced colorectal cancer ? N. Perez-Staub, B. Chibaudel, A. Figer, A. Cervantes,
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
David Cibula, VFN Innovation in surgical approach of ovarian cancer David Cibula Gynecologic Oncology Centre General Faculty Hospital in Prague.
Debulking in Ovarian Cancer Ashraf Fawzy Nabhan Assistant Prof. of Obstetrics & Gynecology Ain Shams University, Cairo, Egypt.
Gallbladder Cancer Surgical Management
Case report Ovarian cancer Ami Fishman, M.D. Meir Hospital - Sapir Med Center Kfar-Saba, Israel Ovarian cancer Ami Fishman, M.D. Meir Hospital.
PANCREATODUODENECTOMY + MULTIVISCERAL RESECTION YES/NO
Primary Debulking vs NACT+IDS in EOC (PFS/OAS/Morbidity)
Over 1,000 robotic surgeries performed to date, and counting
Gazi ABDULHAY, Sebile GÜLER ÇEKİÇ
AOC Surgical Outcome Survey
Short-term outcome of neo-adjuvant chemotherapy
Uterine serous carcinoma is more aggressive than high-grade serous ovarian carcinoma: a retrospective study H. Nagano1, Y. Tachibana1, M. Kawakami1, M.
Title Introduction Methods Results Discussion Authors
Figure #1 Overall survival Figure #2 Disease free survival
Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven
Peritoneal metastases can be cured
Surgical Treatment of Different Types of Pancreatic Cancers- Clinical Center of Serbia Experiances Vladimir Djordjevic, Nemanja Zaric, Zeljko Radojkovic,
Chad Burk, MD Radiology, PGY-4 Loma Linda University
OPTIMIZING TREATMENT FOR ADVANCED OVARIAN CANCER:
HEPATIC RESECTION FOR PARENCHIMATOUS OVARIAN CANCER LIVER METASTASES BEYOND SECONDARY CYTOREDUCTION FOR RELPASED OVARIAN CANCER Nicolae Bacalbasa1,
Transradial Intervention as Access of Choice in STEMI
Percutaneous Cryoablation of Metastatic Ovarian Cancer for Local Tumor Control: Improved Patient Survival and Estimated Cost-Effectiveness Brandt P. Currier.
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer:
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Traian Dumitrascu Andra Scarlat, Mihnea Ionescu, Irinel Popescu
Prepared by staff in Prevention and Cancer Control.
The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement.
Effect of NACT on optimal debulking in advanced EOC-A retrospective study at a tertiary cancer centre Investigator: Dr.Rekha.B.R Fellow-gynec onco Guide:
PDS vs NACT+İDS İn ASEOC
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Presentation transcript:

{ Upper Abdominal Debulking of Gynecologic Malignancies Shaun McKenzie, MD Assistant Professor of Surgery University of Kentucky

 To describe the rationale behind the inclusion of upper abdominal debulking procedures to achieve complete cytoreduction  To review the pertinent anatomy and techniques necessary for upper abdominal debulking  To describe the perioperative outcomes associated with an aggressive upper abdominal approach Objectives

 Extensive upper abdominal disease portends aggressive tumor biology precluding a benefit from surgery  The morbidity and mortality of upper abdominal debulking is prohibitive  Lack of comfort in performance of these procedures or lack of appreciation of the biology of these diseases and the importance of optimal cytoreduction Obstacles to an Aggressive Approach

Aggressive Surgical Effort and Improved Survival in Advanced Stage Ovarian Cancer  Retrospective analysis of 194 patients  Need for radical surgery did not adversely impact survival  In patients with carcinomatosis, performance of radical surgery was associated with improved survival (44% vs 17%,p<0.001)  The only independent predictor of survival was residual disease Aletti et al. Obstet Gynecol 2006; 107: 77-85

Aggressive Surgical Effort and Improved Survival in Advanced Stage Ovarian Cancer Aletti et al. Obstet Gynecol 2006; 107: 77-85

 Diaphragmatic procedures: stripping or resection, ABC  Splenectomy with or without distal pancreatectomy  Porta hepatis resection  Liver resection  Cholecystectomy  Gastric resection Upper Abdominal Debulking Procedures

 262 consecutive patients  Addition of upper abdominal resections increased OC from 53% to 82%  Required in 1/3 of patients  No difference between complication rate between groups  No survival difference between OC groups with or without upper abdominal debulking Eisenhauer et al. Gynecol Oncol 2006; 103

Chi et al. Gynecol Oncol 2009;114

 Wide Exposure and thorough organ mobilization  Critical Understanding of the Anatomy, particularly vascular anatomy  Understand the predictable sites of disease  Bring all your toys to the table Principles of Upper Abdominal Debulking

Diaphragmatic Procedures Fanfani et al. Gynecol Oncol 2009; 116

Is It Safe?  141 eligible patients with 229 EUAS procedures performed  90 % optimally reduced (30% R0)  Grade 3-5 morbidity in 22%  68% of complications managed by a percutaneous procedure  Mortality 1.4% Chi et al. Gynecol Oncol 2010; 119

 Optimal Cytoreduction should be the plan of attack for any woman undergoing debulking surgery  The addition of an aggressive approach to upper abdominal disease is associated with increased rates of optimal debulking without a negative impact in cancer outcome  EUAS can be performed safely in experienced centers with a multidisciplinary approach  Adherance to sound surgical principles optimizes outcome Conclusion